Laura Lelenwa

Statistics

Publications

Citations

617

H-Index

Active since

2019

Affiliations

The University of Texas Health Science Center at Houston(Current)

Memorial Hermann

Texas Medical Center

University of Milan

Laura Lelenwa is an author at The University of Texas Health Science Center at Houston specializing in cardiovascular pathology, immunology, and checkpoint inhibitor therapy.

ORCID

Publications per year

2019–2021

Publications

The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities

L. Maximilian Buja, Dwayne A. Wolf, Bihong Zhao et al. · Cardiovascular Pathology · 2020 · 398 citations · Full text

Veterinary Medicine, Infectious Diseases, Pathology +14

Immune checkpoint inhibitor myocarditis: elucidating the spectrum of disease through endomyocardial biopsy

Nicolas L. Palaskas, Ana Segura, Laura Lelenwa et al. · European Journal of Heart Failure · 2021 · 124 citations · Full text

Life Sciences, Cardiology, Immunology +14

The Terrible Triad of Checkpoint Inhibition: A Case Report of Myasthenia Gravis, Myocarditis, and Myositis Induced by Cemiplimab in a Patient with Metastatic Cutaneous Squamous Cell Carcinoma

Nikeshan Jeyakumar, Mikel Etchegaray, Jason T. Henry et al. · Case Reports in Immunology · 2020 · 51 citations · Full text

Life Sciences, Immunology, Oncology +17

Acute myeloid leukemia with mutated <i>NPM1</i> mimics acute promyelocytic leukemia presentation

Manuel J. Arana Rosainz, Nghia D. Nguyen, Amer Wahed et al. · International Journal of Laboratory Hematology · 2020 · 24 citations

Medicine, Hematology, Oncology +17

Clinicopathological manifestations of myocarditis in a heart failure population

L. Maximilian Buja, Giulia Ottaviani, Milica Ilić et al. · Cardiovascular Pathology · 2019 · 20 citations

Medicine, Cardiology, Pathology +12

1–5 of 5